CD44 and neoplasm: We performed “wound healing” assays to evaluate the effect on cell migration of MCF-7 and IBH-7 incubated with control-, hATN- and hATT-CMs pre-treated (or not) with chondroitinase ABC, an enzyme that degrades versican’s GAG chains, therefore preventing effective interaction between versican and tumor cells (via CD44).